19 October 2022 in Turkish Journal of Gastroenterology
Background: Regular coffee consumption has beneficial and preventative effects on liver and chronic neurodegenerative diseases. However, the studies performed with the ingredients found in coffee beverages have not clarified the responsible mechanisms. Exosomes are small, membrane-coated cargo packages secreted by prokaryote and eukaryote cells. Exosomes regulate intercellular communication and affect cellular metabolic activities even among different species. In this study, we aimed to isolate and characterize the edible plant-derived exosome-like nanoparticles from roasted hot coffee beverages, hypothesizing that the edible plant-derived exosome-like nanoparticles were responsible for the beneficial effects of coffee. Methods: Size exclusion chromatography and commercial kits were used for the isolation process. Efficient coffee edible plant-derived exosome-like nanoparticle fractions were determined by an ultraviolet-visible spectrophotometer. Harvested coffee edible plant-derived exosome-like nanoparticles were characterized by transmission electron microscopy. The quantification procedure was performed using a commercial kit. Coffee edible plant-derived exosome-like nanoparticles’ proliferative effects on human hepatic stellate cells and human hepatocellular carcinoma cells were studied using an MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) assay. Whole-exosome RNA sequencing was performed. Results: Transmission electron microscopy scanning analysis indicated round-shaped nanoparticles with sizes ranging from 40 to 100 nm. Both size exclusion chromatography and kit-isolated edible plant-derived exosome-like nanoparticle samples showed maximum absorbance at 227.5 nm in ultraviolet-visible spectrophotometer analysis. Regarding the quantitation results, kit isolation was more efficient than the size exclusion chromatography method when the harvested particle numbers were compared. An important MTT assay finding confirmed the observed beneficial effects of coffee beverages: coffee edible plant-derived exosome-like nanoparticles significantly suppressed hepatocellular carcinoma cell proliferation. As a result of sequencing, we identified 15 mature miRNAs. A MapReduce-based MicroRNA Target Prediction Method (The DIANA tools’ MR-microT algorithm) highlighted 2 genes specifically associated with the miRNAs that we obtained: KMT2C and ZNF773. Conclusion: For the first time in the literature, coffee edible plant-derived exosome-like nanoparticles were identified. These nanoparticles may have therapeutic effects on chronic liver diseases. Experimental studies, therefore, should be performed on disease models to demonstrate their efficacy. Cite this article as: Kantarcıoğlu M, Yıldırım G, Akpınar Oktar P, et al. Coffee-derived exosome-like nanoparticles: Are they the secret heroes? Turk J Gastroenterol. 2023;34(2):161-169.
19 June 2009 in Endoscopy
A 28-year-old man was referred to us with a diagnosis of acute pancreatitis. The patient had experienced abdominal pain, nausea, and vomiting. In the 2 months prior to admission, he had been admitted and treated for acute pancreatitis twice in another hospital. He had no history of alcohol intake or habitual drug use. The physical examination was unremarkable except for epigastric tenderness, but his amylase level was markedly raised (2461 IU/L [normal range < 480 IU/L]). Abdominal ultrasonography and computed tomography (CT) revealed mild edematous acute pancreatitis without gallstones. The CT scan also showed a large (2.5 cm × 1.5 cm), well-circumscribed mass in the second part of the duodenum ([ Fig. 1 ]). Magnetic resonance cholangiopancreatography demonstrated normal common bile duct and pancreatic duct. Endoscopic retrograde cholangiopancreatography (ERCP) was carried out, and a large, pedunculated polyp, originating from the second part of the duodenum and extending further down into the third part over the ampulla of Vater, was visualized during the procedure ([ Fig. 2 ] and [ Video 1 ]). Polypectomy was done using a standard snare, and minor bleeding following the procedure was controlled by injecting epinephrine. Histologically, the polyp consisted of branching bundles of muscle fibers derived from the muscularis mucosa and covered by hyperplastic duodenal mucosa, compatible with a Peutz–Jeghers-type hamartomatous polyp ([ Fig. 3 ]). The patient had no mucocutaneous pigmentation suggestive of Peutz–Jeghers syndrome and the family history was negative. A total ileocolonoscopy was done, but the findings were normal. The patient has remained well at 9 months after discharge without further recurrence of pancreatitis. The earlier recurrence of acute pancreatitis was attributed to intermittent obstruction of the papilla of Vater by the hamartomatous polyp. Fig. 1 Axial contrast-enhanced CT scan showing a homogeneous, well-circumscribed mass (arrow) with a diameter of 2.5 cm in the second part of the duodenum and loss of homogeneity of the peripancreatic mesenteric fat planes. Fig. 2 Endoscopic retrograde cholangiopancreatography (ERCP) revealing a large, pedunculated polyp with a thick stalk originating in the second part of the duodenum and extending into the third part of the duodenum. Fig. 3 Low-power view of the resected specimen showing a cauliflower-like polypoid lesion with dilated vascular channels traversing its stalk. b Several cystic glands as well as smooth muscle bundles originating from the muscularis mucosa and extending towards the subepithelial connective tissue can also be seen. The epithelium was hyperplastic in nature but there was no dysplasia. To date, only a few well-documented cases of a solitary Peutz–Jeghers-type hamartomatous polyp of the duodenum without other features of Peutz–Jeghers syndrome have been reported. This type of hamartomatous polyp is now considered as a separate disease entity from Peutz–Jeghers syndrome [ 1 ] [ 2 ]. To our knowledge, this report represents the first case of recurrent acute pancreatitis caused by a solitary Peutz–Jeghers-type hamartomatous polyp in the duodenum. Endoscopy_UCTN_Code_CCL_1AB_2AZ_3AB
1 January 2021 in Hepatology Forum
29 September 2026 in PeerJ
Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-beta 1–42 (Aβ 1–42 ) accumulation, tau pathology, and metabolic dysfunction. This exploratory study evaluated the effects of coffee-derived exosome-like nanoparticles (CELNs) on selected metabolic and histopathological endpoints in a fibrillar Aβ 1–42 -induced neurodegenerative rat model. Methods: Fifty male Sprague–Dawley rats were randomly divided into five groups ( N = 10 each): Control (C), sham (SF), a fibrillar Aβ 1–42 -induced neurodegenerative rat model (AD), AD treated with a low dose of CELNs (AD + LE, 10 mg/kg/day), and AD treated with a high dose of CELNs (AD + HE, 20 mg/kg/day) for 14 days. CELNs were quantified and characterized using the bicinchoninic acid method, scanning electron microscopy, and nanoparticle tracking analysis (NTA). Micro-positron emission tomography/computed tomography fluorodeoxyglucose (MicroPET/CT FDG) imaging of the central nervous system was performed in all groups at the end of treatment. Subsequently, all animals were sacrificed, and hippocampal tissues were subjected to histopathological analysis. Results: MicroPET imaging demonstrated a significant, dose-dependent increase in cerebral glucose metabolism in AD rats treated with CELNs compared with the untreated AD group. Histopathological evaluations were consistent with the imaging data: in AD groups receiving CELNs, phospho-tau and beta-amyloid precursor protein expression were significantly reduced in the hippocampal cornu ammonis 2 (CA2) and dentate gyrus regions compared with the untreated AD group. Conclusions: In this exploratory fibrillar Aβ 1–42 -induced neurodegenerative rat model, oral CELN administration was associated with dose-dependent partial improvements in cerebral glucose metabolism and region-specific reductions in hippocampal phosphorylated tau (p-Tau) and amyloid precursor protein (APP) immunoreactivity. However, these are preliminary biomarker-level findings that support further investigation of CELNs; definitive confirmation of functional and cognitive benefits requires additional behavioral, biodistribution, and experimental validation.
14 March 2014 in Aging Clinical and Experimental Research